CoChat

The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.

Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models

Open access

Abstract

Neuromelanin (NM) accumulates in catecholamine long-lived brain neurons that are lost in neurodegenerative diseases. NM is a complex substance made of melanic, peptide and lipid components. NM formation is a natural protective process since toxic endogenous metabolites are removed during its formation and as it binds excess metals and xenobiotics. However, disturbances of NM synthesis and function could be toxic. Here, we review recent knowledge on NM formation, toxic mechanisms involving NM, go over NM binding substances and suggest experimental models that can help identifying xenobiotic modulators of NM formation or function. Given the high likelihood of a central NM role in age-related human neurodegenerative diseases such as Parkinson’s and Alzheimer’s, resembling such diseases using animal models that do not form NM to a high degree, e.g., mice or rats, may not be optimal. Rather, use of animal models (i.e., sheep and goats) that better resemble human brain aging in terms of NM formation, as well as using human NM forming stem cellbased in vitro (e.g., mid-brain organoids) models can be more suitable. Toxicants could also be identified during chemical synthesis of NM in the test tube.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antiox10060824

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Figures

Scheme 1 The hypothesized biosynthetic pathway of NM is schematically shown to proceed through four main phases. In the initial Phase 1, the oxidation products of DA, or the oxidized DA metabolites [22], generated by catalytic oxidation mediated by Fe3+, or Cu2+, react with fibrillary seeds of aggregated peptides/proteins (blue) at the exposed side chains of Cys, His and Lys forming melanin (orange)-protein conjugates maintaining the fibrillary core as the only structural element. In Phase 2, the undegradable conjugates are engulfed by the phagophore and isolated from the cytosol through a double lipid membrane (yellow). The autophagic vacuoles fuse with lysosomes (blue circle) in Phase 3, causing interaction between the melanin-protein conjugates with other proteins, enzymes and lipids carried by lysosomes, and are transformed into autolysosomes. The resulting autolysosomes fuses with other vesicles containing lipids that attach to melanin-protein conjugates to form NM. Finally, in Phase 4 these organelles fuse with other autophagic vacuoles containing NM precursors or with mature NM organelles. A more detailed description of the entire process can be found in Zucca et al., 2018 [14].
Scheme 1 The hypothesized biosynthetic pathway of NM is schematically shown to proceed through four main phases. In the initial Phase 1, the oxidation products of DA, or the oxidized DA metabolites [22], generated by catalytic oxidation mediated by Fe3+, or Cu2+, react with fibrillary seeds of aggregated peptides/proteins (blue) at the exposed side chains of Cys, His and Lys forming melanin (orange)-protein conjugates maintaining the fibrillary core as the only structural element. In Phase 2, the undegradable conjugates are engulfed by the phagophore and isolated from the cytosol through a double lipid membrane (yellow). The autophagic vacuoles fuse with lysosomes (blue circle) in Phase 3, causing interaction between the melanin-protein conjugates with other proteins, enzymes and lipids carried by lysosomes, and are transformed into autolysosomes. The resulting autolysosomes fuses with other vesicles containing lipids that attach to melanin-protein conjugates to form NM. Finally, in Phase 4 these organelles fuse with other autophagic vacuoles containing NM precursors or with mature NM organelles. A more detailed description of the entire process can be found in Zucca et al., 2018 [14].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 143 references

Cited by

See all 36

Metadata

Authors
Capucciati, A., Zucca, F. A., Monzani, E., Zecca, L., Casella, L., & Hofer, T.
Affiliations
  • University of Pavia (IT)
  • Institute of Biomedical Technologies (IT)
  • Norwegian Institute of Public Health (NO)
Corresponding author
Hofer, Tim
Venue
Antioxidants
Publisher
MDPI AG
Published
2021-05-21
Volume
10
Issue
6
Pages
824
ISSN
2076-3921 (ISSN-L)
OpenAlex
W3165207429
Cited by
36
References
143
Citations by year
2026: 2 · 2025: 11 · 2024: 4 · 2023: 12 · 2022: 6 · 2021: 1
FWCI
0.74
Type
journal article
Language
en
Open access
Locations
  • Antioxidants (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
Funders
Ministero dell’Istruzione, dell’Università e della Ricerca (2015T778JW)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
Keywords
neuromelanin, xenobiotics, neurodegeneration, catecholaminergic neurons, metal ion binding, neurotoxicity, Parkinson's disease, Alzheimer's disease, brain aging, toxicant identification

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models. https://app.cochat.ai/papers/10.3390/antiox10060824
The paper
Capucciati, A., Zucca, F. A., Monzani, E., Zecca, L., Casella, L., & Hofer, T. (2021). Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models. Antioxidants. https://doi.org/10.3390/antiox10060824

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.